Citation: D. Glicklich et A. Acharya, MYCOPHENOLATE MOFETIL THERAPY FOR LUPUS NEPHRITIS REFRACTORY TO INTRAVENOUS CYCLOPHOSPHAMIDE, American journal of kidney diseases, 32(2), 1998, pp. 318-322
Citation: P. Lazowski et al., RECURRENT CRESCENTIC MEMBRANOUS NEPHROPATHY IN 2 SUCCESSIVE RENAL-TRANSPLANTS - ASSOCIATION WITH CHOROIDAL EFFUSIONS AND RETINAL-DETACHMENT, American journal of nephrology, 18(2), 1998, pp. 146-150
Authors:
GLICKLICH D
MANSUR A
GILMAN J
SANTARINA L
TELLIS V
Citation: D. Glicklich et al., ANGIOTENSIN-CONVERTING ENZYME (ACE) POLYMORPHISMS IN IDIOPATHIC FOCALSEGMENTAL SCLEROSIS (FS), Journal of the American Society of Nephrology, 8, 1997, pp. 333-333
Authors:
GLICKLICH D
SCHURTER G
GREENSTEIN S
MALLIS M
CLEMETSON S
TELLIS V
Citation: D. Glicklich et al., MYCOPHENOLATE MOFETIL (MMF) THERAPY FOR CHRONIC REJECTION IN RENAL-TRANSPLANT (RTX) RECIPIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 3181-3181
Citation: D. Glicklich, WHEN AND HOW SHOULD DIALYSIS PATIENTS WITH ANTI-HEPATITIS-C ANTIBODIES BE TREATED, Seminars in dialysis, 10(5), 1997, pp. 252-254
Authors:
GREENSTEIN SM
KATZ S
SUN SI
GLICKLICH D
SCHECHNER R
KUTCHER R
TELLIS V
Citation: Sm. Greenstein et al., PREVALENCE OF ASYMPTOMATIC CHOLELITHIASIS AND RISK OF ACUTE CHOLECYSTITIS AFTER KIDNEY-TRANSPLANTATION, Transplantation, 63(7), 1997, pp. 1030-1032
Authors:
KAPOIAN T
CROIZAT H
GLICKLICH D
GREENSTEIN S
SCHECHNER R
TELLIS V
Citation: T. Kapoian et al., ENALAPRILAT (ELT) INHIBITS IN-VITRO BFU-E GROWTH IN PATIENTS WITH POST TRANSPLANT ERYTHROCYTOSIS (PTE), Journal of the American Society of Nephrology, 7(9), 1996, pp. 3201-3201
Authors:
GLICKLICH D
AHUJA T
MALLIS M
CLEMETSON S
TELLIS V
GREENSTEIN S
SCHECHNER R
Citation: D. Glicklich et al., EFFICACY OF LOSARTAN (L) THERAPY FOR HYPERTENSION (HTN) IN RENAL-TRANSPLANT (RT) PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3311-3311
Authors:
GREENSTEIN M
NEUGARTEN J
GLICKLICH D
SCHECHNER RS
TELLIS VA
Citation: M. Greenstein et al., THE RELEVANCE OF RACE IN CYCLOSPORINE-TREATED CADAVER RENAL-TRANSPLANTS (CRT) - 10-YEAR EXPERIENCE, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3316-3316
Citation: D. Glicklich et T. Kapoian, SHOULD THE HEPATITIS-C POSITIVE END-STAGE RENAL-DISEASE PATIENT BE TRANSPLANTED, Seminars in dialysis, 9(1), 1996, pp. 5-8
Authors:
GLICKLICH D
KAPOIAN T
REINUS J
GREENSTEIN S
PRINCIPE A
TELLIS V
Citation: D. Glicklich et al., CLINICAL AND HISTOLOGIC FEATURES IN HEPATITIS-C (HCV) INFECTED RENAL-TRANSPLANT (RT) AND DIALYSIS (D) PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1086-1086
Citation: D. Glicklich et al., NITRIC-OXIDE METABOLITES IN ACUTE RENAL-ALLOGRAFT REJECTION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1087-1087
Authors:
GLICKLICH D
GREENSTEIN S
MALLIS M
CLEMETSON S
SCHECHNER R
TELLIS V
Citation: D. Glicklich et al., EFFICACY OF PROGRAF (FK606) RESCUE THERAPY IN RENAL-TRANSPLANT (RT) PATIENTS WITH ACUTE REJECTION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1093-1093
Authors:
GLICKLICH D
REINUS J
GREENSTEIN S
SCHECHNER R
MALLIS M
CLEMETSON S
TELLIS V
Citation: D. Glicklich et al., HEPATITIS-C (HCV) INFECTION IN RENAL-TRANSPLANT (RT) RECIPIENTS - HISTOLOGY AND CLINICAL-FEATURES, Journal of the American Society of Nephrology, 5(3), 1994, pp. 1006-1006
Authors:
ROGERS J
GREENSTEIN S
SCHECHNER R
GLICKLICH D
CLEMETSON S
MALLIS M
TELLIS V
Citation: J. Rogers et al., INDUCTION WITH POLYCLONAL ANTIBODY IN RENAL-TRANSPLANTATION - COMPARISON OF 2 PREPARATIONS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 1033-1033
Authors:
STEIN M
ANDERSON C
RICCIARDI R
CHAMBERLIN JW
LERNER SE
GLICKLICH D
Citation: M. Stein et al., PENILE GANGRENE ASSOCIATED WITH CHRONIC-RENAL-FAILURE - REPORT OF 7 CASES AND REVIEW OF THE LITERATURE, The Journal of urology, 152(6), 1994, pp. 2014-2016